May 11, 2021 09:21 PM (GMT+8) · EqualOcean
Shanghai Pharmaceutical announced that in order to support the company's long-term business development, improve the industrial layout and further enhance the company's overall strength, the company plans to introduce Yunnan Baiyao as a strategic investor through this non-public offering of a shares. The company and Yunnan Baiyao signed the conditional strategic cooperation agreement between Shanghai Pharmaceutical Group Co., Ltd. and Yunnan Baiyao Group Co., Ltd., which agreed on specific matters of strategic cooperation.

This text is a result of machine translation.